Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
AssigneeRegentis Biomaterials Ltd.
InventorsDror Seliktar, Liora Almany
Life of this patent
Estimating the term…
Abstract
A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
Claims10
A method of regenerating a bone tissue or cartilage tissue, the method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer covalently attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in said subject, thereby regenerating the bone tissue or cartilage tissue.
A method of regenerating a bone tissue or cartilage tissue, the method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in said subject, thereby regenerating the bone tissue or cartilage tissue, wherein said composition is formulated for systemic administration.
A method of regenerating a bone tissue or cartilage tissue, the method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in said subject, thereby regenerating the bone tissue or cartilage tissue, wherein said synthetic polymer is PEG and wherein a molar ratio between said PEG to said fibrinogen is between 100:1 and 1000:1.
Dependencies are inferred from the claim text.